Page last updated: 2024-10-23

atenolol and Conus Medullaris Syndrome

atenolol has been researched along with Conus Medullaris Syndrome in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneider, GS1
Gugssa, SA1
Johnston, JC1

Reviews

1 review available for atenolol and Conus Medullaris Syndrome

ArticleYear
Syphilitic aortic aneurysm with spastic paraparesis: a novel presentation and review of the literature.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Aorta, Thoracic; Aortic Aneurysm, Thoracic; Atenolol; Disease Outbreaks; Disease Progression; Drug T

2012

Other Studies

1 other study available for atenolol and Conus Medullaris Syndrome

ArticleYear
Anterior spinal cord syndrome after initiation of treatment with atenolol.
    The Journal of emergency medicine, 2010, Volume: 38, Issue:5

    Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Hypertension; Hypotension; Infarction; Intervertebral

2010